Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

Also reported by 2 other outlets

Read the original at cnbc.com →

More in Health & Medicine

More from Wednesday 30 September →